# Editorial: Electroconvulsive therapy: from mechanisms to clinical practice

**Authors:** Cristiana Țăpoi, Laith Alexander, Mariana Pinto da Costa, João Quevedo, Mario F. Juruena

PMC · DOI: 10.3389/fpsyt.2025.1727912 · Frontiers in Psychiatry · 2025-11-10

## Full-text entities

- **Genes:** BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}
- **Diseases:** -resistant depression (MESH:D061218), inflammatory (MESH:D007249), schizophrenia (MESH:D012559), psychosis (MESH:D011618), ECT (MESH:D016609), mental illness (MESH:D001523), overactive bladder (MESH:D053201), bipolar disorder (MESH:D001714), depression (MESH:D003866), status epilepticus (MESH:D013226), fever (MESH:D005334), seizure (MESH:D012640)
- **Chemicals:** ketamine (-), lorazepam (MESH:D008140), etomidate (MESH:D005045), propofol (MESH:D015742)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12642602/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12642602/full.md

---
Source: https://tomesphere.com/paper/PMC12642602